drugset / Trial / NCT03302091
A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the current study is to investigate the influence of moderate renal impairment on the pharmacokinetics of multiple doses in comparison to a matched control group with normal renal function.
Timeline
- Start
- 2017-10-17
- Primary completion
- 2018-08-16
- Completion
- 2018-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1467335 | Unknown | — | — |